Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erica Winter

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Current Reviews in Clinical and Experimental Pharmacology|March 17, 2021
Current Advances in Clinical Trials for Rare Disease Populations: Spotlight on the PatientErica Winter, Scott Schliebner
AIDS Research and Therapy|September 2, 2008
Predictive validity of a brief antiretroviral adherence index: retrospective cohort analysis under conditions of repetitive administrationWilliam C Mathews, Eva Barker, Erica Winter, et al.
Clinical Pharmacology and Therapeutics|November 5, 2020
Pharmacology-Guided Rule-Based Adaptive Dose Escalation in First-in-Human StudiesEwoud-Jan van Hoogdalem, Mattheus Thijs van Iersel, Erica Winter, et al.
Clinical Pharmacology and Therapeutics|October 14, 2022
Population Pharmacokinetic Modeling for Ceftazidime-Avibactam Renal Dose Adjustments in Pediatric Patients 3 months and OlderRichard Franzese, Todd Riccobene, Timothy Carrothers, et al.
Clinical and Translational Science|December 21, 2025
A First-in-Human, Single- and Multiple-Dose Study of APG777, a Half-Life-Extended Anti-IL-13 Monoclonal Antibody, in Healthy VolunteersXiu Qin Lim, Erica Winter, Kristine Nograles, et al.
Clinical Pharmacology in Drug Development|October 26, 2022
Safety, Tolerability, and Pharmacokinetics of Intravenous Doses of PF-07304814, a Phosphate Prodrug Protease Inhibitor for the Treatment of SARS-CoV-2, in Healthy Adult ParticipantsTong Zhu, Sylvester Pawlak, Sima S Toussi, et al.
Antimicrobial Agents and Chemotherapy|February 12, 2020
Safety and Pharmacokinetic Characterization of Nacubactam, a Novel β-Lactamase Inhibitor, Alone and in Combination with Meropenem, in Healthy VolunteersNavita L Mallalieu, Erica Winter, Scott Fettner, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Current Reviews in Clinical and Experimental Pharmacology|March 17, 2021
Current Advances in Clinical Trials for Rare Disease Populations: Spotlight on the PatientErica Winter, Scott Schliebner
AIDS Research and Therapy|September 2, 2008
Predictive validity of a brief antiretroviral adherence index: retrospective cohort analysis under conditions of repetitive administrationWilliam C Mathews, Eva Barker, Erica Winter, et al.
Clinical Pharmacology and Therapeutics|November 5, 2020
Pharmacology-Guided Rule-Based Adaptive Dose Escalation in First-in-Human StudiesEwoud-Jan van Hoogdalem, Mattheus Thijs van Iersel, Erica Winter, et al.
Clinical Pharmacology and Therapeutics|October 14, 2022
Population Pharmacokinetic Modeling for Ceftazidime-Avibactam Renal Dose Adjustments in Pediatric Patients 3 months and OlderRichard Franzese, Todd Riccobene, Timothy Carrothers, et al.
Clinical and Translational Science|December 21, 2025
A First-in-Human, Single- and Multiple-Dose Study of APG777, a Half-Life-Extended Anti-IL-13 Monoclonal Antibody, in Healthy VolunteersXiu Qin Lim, Erica Winter, Kristine Nograles, et al.
Clinical Pharmacology in Drug Development|October 26, 2022
Safety, Tolerability, and Pharmacokinetics of Intravenous Doses of PF-07304814, a Phosphate Prodrug Protease Inhibitor for the Treatment of SARS-CoV-2, in Healthy Adult ParticipantsTong Zhu, Sylvester Pawlak, Sima S Toussi, et al.
Antimicrobial Agents and Chemotherapy|February 12, 2020
Safety and Pharmacokinetic Characterization of Nacubactam, a Novel β-Lactamase Inhibitor, Alone and in Combination with Meropenem, in Healthy VolunteersNavita L Mallalieu, Erica Winter, Scott Fettner, et al.
Pageof 1